Premier Asset Management LLC Eli Lilly & CO Transaction History

Premier Asset Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $209,007 - $243,535	650 Added 35.23%	2,495 $912,000
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $314,268 - $358,142	1,060 Added 135.03%	1,845 $597,000
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $218,803 - $256,906	785 New	785 $259,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Premier Asset Management LLC with notifications on news.